The Influence of Oxytocin on Automatic Imitation Behaviour in Healthy Adults
1 other identifier
interventional
60
1 country
1
Brief Summary
In this study, the influence of oxytocin on automatic imitation behaviour is investigated. Healthy adults will be administered with either oxytocin or a placebo, and will perform an imitation-inhibition task (as a measure of automatic imitation behaviour). To determine the specificity of the oxytocin effect, an unrelated cognitive task (Stroop task) will also be presented.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_3 healthy
Started Nov 2012
Shorter than P25 for phase_3 healthy
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2012
CompletedFirst Submitted
Initial submission to the registry
January 10, 2013
CompletedFirst Posted
Study publicly available on registry
January 11, 2013
CompletedJanuary 17, 2013
January 1, 2013
1 month
January 10, 2013
January 16, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To evaluate the automatic imitation behaviour 45 minutes after drug administration
Since the effects of oxytocin are only visible after 45 minutes, participants will have to wait 45 minutes before starting the experimental tasks. In the meantime, they will be given an unrelated cognitive-emotional filler task which will last ± 30 minutes. Afterwards, they will perform two experimental tasks: an imitation-inhibition task and a cognitive control task (Stroop task).
120 minutes
Study Arms (2)
Oxytocin
EXPERIMENTALOxytocin 24 IU (3 puffs) per nostril
Sea water
PLACEBO COMPARATORSea water 3 puffs per nostril
Interventions
Eligibility Criteria
You may qualify if:
- Male
- non-smoker
You may not qualify if:
- no pacemaker, deep brain stimulation electrodes or other stimulation devices
- normal neurological history (no brain operations, migraine, epilepsy, alcoholism
- no epilepsy in family
- no chronic disease(s) that require constant medication (asthma, hypertension, diabetes)
- no medication 24h prior to experiment
- no alcohol or caffeine 2h prior to experiment
- no sleep deprivation 24h prior to experiment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Ghentlead
- Research Foundation Flanderscollaborator
Study Sites (1)
Ghent University, Faculty of Psychology and Educational Sciences
Ghent, 9000, Belgium
MeSH Terms
Conditions
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Guy T'Sjoen, MD, PhD
Ghent University, Faculty of Endrocrinology
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 10, 2013
First Posted
January 11, 2013
Study Start
November 1, 2012
Primary Completion
December 1, 2012
Study Completion
December 1, 2012
Last Updated
January 17, 2013
Record last verified: 2013-01